The Impact of Incretin-Based Medications on Lipid Metabolism

Pathophysiological pathways that are induced by chronic hyperglycemia negatively impact lipid metabolism. Thus, diabetes is commonly accompanied by varying degrees of dyslipidemia which is itself a major risk factor for further macro- and microvascular diabetes complications such as atherosclerosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaribeygi, Habib, Maleki, Mina, Butler, Alexandra E., Jamialahmadi, Tannaz, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731296/
https://www.ncbi.nlm.nih.gov/pubmed/35005028
http://dx.doi.org/10.1155/2021/1815178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731296/
https://www.ncbi.nlm.nih.gov/pubmed/35005028
http://dx.doi.org/10.1155/2021/1815178

Ejemplares similares